Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model.
Int J Pharm X. 2022 Nov 13;4:100139. doi: 10.1016/j.ijpx.2022.100139. eCollection 2022 Dec.
Int J Pharm X. 2022.
PMID: 36420371
Free PMC article.
WITHDRAWN: In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model.
Vinh Nguyen P, Hervé-Aubert K, Lajoie L, Misericordia Y, Chourpa I, David S, Allard-Vannier E.
Vinh Nguyen P, et al. Among authors: misericordia y.
Int J Pharm. 2023 Feb 5;632:122335. doi: 10.1016/j.ijpharm.2022.122335. Epub 2022 Oct 22.
Int J Pharm. 2023.
PMID: 36283640
Item in Clipboard
Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for Efficient Anti-Cancer Activity in HER2+ Breast Cancer Cells.
Eljack S, Allard-Vannier E, Misericordia Y, Hervé-Aubert K, Aubrey N, Chourpa I, Faggad A, David S.
Eljack S, et al. Among authors: misericordia y.
Pharmaceutics. 2022 Nov 21;14(11):2537. doi: 10.3390/pharmaceutics14112537.
Pharmaceutics. 2022.
PMID: 36432729
Free PMC article.
Item in Clipboard
Cite
Cite